vs
Amphastar Pharmaceuticals, Inc.（AMPH）与J&J SNACK FOODS CORP（JJSF）财务数据对比。点击上方公司名可切换其他公司
J&J SNACK FOODS CORP的季度营收约是Amphastar Pharmaceuticals, Inc.的1.9倍（$343.8M vs $183.1M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs 0.3%，领先13.1%），Amphastar Pharmaceuticals, Inc.同比增速更快（-1.8% vs -5.2%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $17.0M），过去两年Amphastar Pharmaceuticals, Inc.的营收复合增速更高（3.2% vs -2.2%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
强生休闲食品公司（J&J Snack Foods Corp.）是美国知名的品牌休闲食品与冷冻饮品生产商、营销商及分销商，总部位于新泽西州芒特劳雷尔，在全美44个州、墨西哥及加拿大设有超175个生产、仓储及配送设施，于纳斯达克全球精选市场上市，业务覆盖国内外市场。
AMPH vs JJSF — 直观对比
营收规模更大
JJSF
是对方的1.9倍
$183.1M
营收增速更快
AMPH
高出3.4%
-5.2%
净利率更高
AMPH
高出13.1%
0.3%
自由现金流更多
AMPH
多$7.6M
$17.0M
两年增速更快
AMPH
近两年复合增速
-2.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $343.8M |
| 净利润 | $24.4M | $883.0K |
| 毛利率 | 46.8% | 27.9% |
| 营业利润率 | 19.4% | 0.2% |
| 净利率 | 13.3% | 0.3% |
| 营收同比 | -1.8% | -5.2% |
| 净利润同比 | -35.7% | -82.8% |
| 每股收益（稀释后） | $0.51 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHJJSF
| Q4 25 | $183.1M | $343.8M | ||
| Q3 25 | $191.8M | $410.2M | ||
| Q2 25 | $174.4M | $454.3M | ||
| Q1 25 | $170.5M | $356.1M | ||
| Q4 24 | $186.5M | $362.6M | ||
| Q3 24 | $191.2M | $426.8M | ||
| Q2 24 | $182.4M | $440.0M | ||
| Q1 24 | $171.8M | $359.7M |
净利润AMPHJJSF
| Q4 25 | $24.4M | $883.0K | ||
| Q3 25 | $17.4M | $11.4M | ||
| Q2 25 | $31.0M | $44.2M | ||
| Q1 25 | $25.3M | $4.8M | ||
| Q4 24 | $38.0M | $5.1M | ||
| Q3 24 | $40.4M | $29.6M | ||
| Q2 24 | $37.9M | $36.3M | ||
| Q1 24 | $43.2M | $13.3M |
毛利率AMPHJJSF
| Q4 25 | 46.8% | 27.9% | ||
| Q3 25 | 51.4% | 31.7% | ||
| Q2 25 | 49.6% | 33.0% | ||
| Q1 25 | 50.0% | 26.9% | ||
| Q4 24 | 46.5% | 25.9% | ||
| Q3 24 | 53.3% | 31.8% | ||
| Q2 24 | 52.2% | 33.6% | ||
| Q1 24 | 52.4% | 30.1% |
营业利润率AMPHJJSF
| Q4 25 | 19.4% | 0.2% | ||
| Q3 25 | 13.2% | 2.8% | ||
| Q2 25 | 24.2% | 13.3% | ||
| Q1 25 | 21.9% | 1.7% | ||
| Q4 24 | 24.2% | 1.7% | ||
| Q3 24 | 29.8% | 9.3% | ||
| Q2 24 | 30.3% | 11.4% | ||
| Q1 24 | 27.9% | 5.0% |
净利率AMPHJJSF
| Q4 25 | 13.3% | 0.3% | ||
| Q3 25 | 9.0% | 2.8% | ||
| Q2 25 | 17.8% | 9.7% | ||
| Q1 25 | 14.8% | 1.4% | ||
| Q4 24 | 20.4% | 1.4% | ||
| Q3 24 | 21.1% | 6.9% | ||
| Q2 24 | 20.8% | 8.3% | ||
| Q1 24 | 25.1% | 3.7% |
每股收益（稀释后）AMPHJJSF
| Q4 25 | $0.51 | $0.05 | ||
| Q3 25 | $0.37 | $0.59 | ||
| Q2 25 | $0.64 | $2.26 | ||
| Q1 25 | $0.51 | $0.25 | ||
| Q4 24 | $0.74 | $0.26 | ||
| Q3 24 | $0.78 | $1.52 | ||
| Q2 24 | $0.73 | $1.87 | ||
| Q1 24 | $0.81 | $0.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $66.8M |
| 总债务越低越好 | $608.7M | — |
| 股东权益账面价值 | $788.8M | $912.9M |
| 总资产 | $1.6B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.77× | — |
8季度趋势，按日历期对齐
现金及短期投资AMPHJJSF
| Q4 25 | $282.8M | $66.8M | ||
| Q3 25 | $276.2M | $105.9M | ||
| Q2 25 | $231.8M | $77.4M | ||
| Q1 25 | $236.9M | $48.5M | ||
| Q4 24 | $221.6M | $73.6M | ||
| Q3 24 | $250.5M | $73.4M | ||
| Q2 24 | $217.8M | $64.0M | ||
| Q1 24 | $289.6M | $43.6M |
总债务AMPHJJSF
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
股东权益AMPHJJSF
| Q4 25 | $788.8M | $912.9M | ||
| Q3 25 | $776.7M | $966.7M | ||
| Q2 25 | $757.5M | $969.9M | ||
| Q1 25 | $751.3M | $935.0M | ||
| Q4 24 | $732.3M | $946.8M | ||
| Q3 24 | $727.7M | $957.0M | ||
| Q2 24 | $713.3M | $937.9M | ||
| Q1 24 | $672.4M | $915.7M |
总资产AMPHJJSF
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.6B | $1.3B |
负债/权益比AMPHJJSF
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $36.0M |
| 自由现金流经营现金流 - 资本支出 | $24.6M | $17.0M |
| 自由现金流率自由现金流/营收 | 13.4% | 4.9% |
| 资本支出强度资本支出/营收 | 4.5% | 5.5% |
| 现金转化率经营现金流/净利润 | 1.35× | 40.73× |
| 过去12个月自由现金流最近4个季度 | $121.2M | $83.1M |
8季度趋势，按日历期对齐
经营现金流AMPHJJSF
| Q4 25 | $32.9M | $36.0M | ||
| Q3 25 | $52.6M | $66.4M | ||
| Q2 25 | $35.6M | $51.2M | ||
| Q1 25 | $35.1M | $12.3M | ||
| Q4 24 | $29.0M | $35.2M | ||
| Q3 24 | $60.0M | $46.3M | ||
| Q2 24 | $69.1M | $65.0M | ||
| Q1 24 | $55.3M | $12.7M |
自由现金流AMPHJJSF
| Q4 25 | $24.6M | $17.0M | ||
| Q3 25 | $47.2M | $44.8M | ||
| Q2 25 | $25.0M | $28.5M | ||
| Q1 25 | $24.4M | $-7.2M | ||
| Q4 24 | $16.6M | $16.1M | ||
| Q3 24 | $46.2M | $29.1M | ||
| Q2 24 | $63.1M | $45.3M | ||
| Q1 24 | $46.5M | $-4.0M |
自由现金流率AMPHJJSF
| Q4 25 | 13.4% | 4.9% | ||
| Q3 25 | 24.6% | 10.9% | ||
| Q2 25 | 14.3% | 6.3% | ||
| Q1 25 | 14.3% | -2.0% | ||
| Q4 24 | 8.9% | 4.4% | ||
| Q3 24 | 24.1% | 6.8% | ||
| Q2 24 | 34.6% | 10.3% | ||
| Q1 24 | 27.1% | -1.1% |
资本支出强度AMPHJJSF
| Q4 25 | 4.5% | 5.5% | ||
| Q3 25 | 2.8% | 5.3% | ||
| Q2 25 | 6.1% | 5.0% | ||
| Q1 25 | 6.3% | 5.5% | ||
| Q4 24 | 6.7% | 5.3% | ||
| Q3 24 | 7.2% | 4.0% | ||
| Q2 24 | 3.3% | 4.5% | ||
| Q1 24 | 5.1% | 4.6% |
现金转化率AMPHJJSF
| Q4 25 | 1.35× | 40.73× | ||
| Q3 25 | 3.03× | 5.84× | ||
| Q2 25 | 1.15× | 1.16× | ||
| Q1 25 | 1.39× | 2.55× | ||
| Q4 24 | 0.76× | 6.84× | ||
| Q3 24 | 1.48× | 1.56× | ||
| Q2 24 | 1.82× | 1.79× | ||
| Q1 24 | 1.28× | 0.96× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
JJSF
| Food Service | $219.2M | 64% |
| Frozen Beverages | $78.7M | 23% |
| Repair And Maintenance Service | $22.5M | 7% |
| Other | $12.7M | 4% |
| Machine Sales | $10.7M | 3% |
